1 Study Coverage
    1.1 Liver Diseases Therapeutics Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral Liver Diseases Therapeutics Drugs
        1.2.3 Injection Liver Diseases Therapeutics Drugs
    1.3 Market by Application
        1.3.1 Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Liver Diseases Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Liver Diseases Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Liver Diseases Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Liver Diseases Therapeutics Drugs Sales by Region
        2.4.1 Global Liver Diseases Therapeutics Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Liver Diseases Therapeutics Drugs by Region (2023-2028)
    2.5 Global Liver Diseases Therapeutics Drugs Revenue by Region
        2.5.1 Global Liver Diseases Therapeutics Drugs Revenue by Region (2017-2022)
        2.5.2 Global Liver Diseases Therapeutics Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Liver Diseases Therapeutics Drugs Sales by Manufacturers
        3.1.1 Global Top Liver Diseases Therapeutics Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liver Diseases Therapeutics Drugs in 2021
    3.2 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers
        3.2.1 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Liver Diseases Therapeutics Drugs Revenue in 2021
    3.3 Global Liver Diseases Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Liver Diseases Therapeutics Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Liver Diseases Therapeutics Drugs Sales by Type
        4.1.1 Global Liver Diseases Therapeutics Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Liver Diseases Therapeutics Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Liver Diseases Therapeutics Drugs Revenue by Type
        4.2.1 Global Liver Diseases Therapeutics Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Liver Diseases Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Liver Diseases Therapeutics Drugs Price by Type
        4.3.1 Global Liver Diseases Therapeutics Drugs Price by Type (2017-2022)
        4.3.2 Global Liver Diseases Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Liver Diseases Therapeutics Drugs Sales by Application
        5.1.1 Global Liver Diseases Therapeutics Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Liver Diseases Therapeutics Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Liver Diseases Therapeutics Drugs Revenue by Application
        5.2.1 Global Liver Diseases Therapeutics Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Liver Diseases Therapeutics Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Liver Diseases Therapeutics Drugs Price by Application
        5.3.1 Global Liver Diseases Therapeutics Drugs Price by Application (2017-2022)
        5.3.2 Global Liver Diseases Therapeutics Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Liver Diseases Therapeutics Drugs Market Size by Type
        6.1.1 North America Liver Diseases Therapeutics Drugs Sales by Type (2017-2028)
        6.1.2 North America Liver Diseases Therapeutics Drugs Revenue by Type (2017-2028)
    6.2 North America Liver Diseases Therapeutics Drugs Market Size by Application
        6.2.1 North America Liver Diseases Therapeutics Drugs Sales by Application (2017-2028)
        6.2.2 North America Liver Diseases Therapeutics Drugs Revenue by Application (2017-2028)
    6.3 North America Liver Diseases Therapeutics Drugs Market Size by Country
        6.3.1 North America Liver Diseases Therapeutics Drugs Sales by Country (2017-2028)
        6.3.2 North America Liver Diseases Therapeutics Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Liver Diseases Therapeutics Drugs Market Size by Type
        7.1.1 Europe Liver Diseases Therapeutics Drugs Sales by Type (2017-2028)
        7.1.2 Europe Liver Diseases Therapeutics Drugs Revenue by Type (2017-2028)
    7.2 Europe Liver Diseases Therapeutics Drugs Market Size by Application
        7.2.1 Europe Liver Diseases Therapeutics Drugs Sales by Application (2017-2028)
        7.2.2 Europe Liver Diseases Therapeutics Drugs Revenue by Application (2017-2028)
    7.3 Europe Liver Diseases Therapeutics Drugs Market Size by Country
        7.3.1 Europe Liver Diseases Therapeutics Drugs Sales by Country (2017-2028)
        7.3.2 Europe Liver Diseases Therapeutics Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Liver Diseases Therapeutics Drugs Market Size by Type
        8.1.1 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Liver Diseases Therapeutics Drugs Market Size by Application
        8.2.1 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Liver Diseases Therapeutics Drugs Market Size by Region
        8.3.1 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Liver Diseases Therapeutics Drugs Market Size by Type
        9.1.1 Latin America Liver Diseases Therapeutics Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Liver Diseases Therapeutics Drugs Revenue by Type (2017-2028)
    9.2 Latin America Liver Diseases Therapeutics Drugs Market Size by Application
        9.2.1 Latin America Liver Diseases Therapeutics Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Liver Diseases Therapeutics Drugs Revenue by Application (2017-2028)
    9.3 Latin America Liver Diseases Therapeutics Drugs Market Size by Country
        9.3.1 Latin America Liver Diseases Therapeutics Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Type
        10.1.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Application
        10.2.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Liver Diseases Therapeutics Drugs Market Size by Country
        10.3.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 F. Hoffmann-La Roche
        11.1.1 F. Hoffmann-La Roche Corporation Information
        11.1.2 F. Hoffmann-La Roche Overview
        11.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 F. Hoffmann-La Roche Recent Developments
    11.2 Gilead Sciences
        11.2.1 Gilead Sciences Corporation Information
        11.2.2 Gilead Sciences Overview
        11.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Gilead Sciences Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Gilead Sciences Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Corporation Information
        11.3.2 GlaxoSmithKline Overview
        11.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Corporation Information
        11.4.2 Johnson & Johnson Overview
        11.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Johnson & Johnson Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Merck
        11.5.1 Merck Corporation Information
        11.5.2 Merck Overview
        11.5.3 Merck Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Merck Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merck Recent Developments
    11.6 Achillion Pharmaceuticals
        11.6.1 Achillion Pharmaceuticals Corporation Information
        11.6.2 Achillion Pharmaceuticals Overview
        11.6.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Achillion Pharmaceuticals Recent Developments
    11.7 AbbVie
        11.7.1 AbbVie Corporation Information
        11.7.2 AbbVie Overview
        11.7.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 AbbVie Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 AbbVie Recent Developments
    11.8 Angion Biomedica
        11.8.1 Angion Biomedica Corporation Information
        11.8.2 Angion Biomedica Overview
        11.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Angion Biomedica Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Angion Biomedica Recent Developments
    11.9 Bayer
        11.9.1 Bayer Corporation Information
        11.9.2 Bayer Overview
        11.9.3 Bayer Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bayer Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bayer Recent Developments
    11.10 LG Life Sciences
        11.10.1 LG Life Sciences Corporation Information
        11.10.2 LG Life Sciences Overview
        11.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 LG Life Sciences Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 LG Life Sciences Recent Developments
    11.11 Phenex Pharmaceuticals
        11.11.1 Phenex Pharmaceuticals Corporation Information
        11.11.2 Phenex Pharmaceuticals Overview
        11.11.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Phenex Pharmaceuticals Recent Developments
    11.12 ProMetic Life Sciences
        11.12.1 ProMetic Life Sciences Corporation Information
        11.12.2 ProMetic Life Sciences Overview
        11.12.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 ProMetic Life Sciences Recent Developments
    11.13 Raptor Pharmaceuticals
        11.13.1 Raptor Pharmaceuticals Corporation Information
        11.13.2 Raptor Pharmaceuticals Overview
        11.13.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Raptor Pharmaceuticals Recent Developments
    11.14 Shenzhen Kangtai Biological Products
        11.14.1 Shenzhen Kangtai Biological Products Corporation Information
        11.14.2 Shenzhen Kangtai Biological Products Overview
        11.14.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Shenzhen Kangtai Biological Products Recent Developments
    11.15 Verva Pharmaceuticals
        11.15.1 Verva Pharmaceuticals Corporation Information
        11.15.2 Verva Pharmaceuticals Overview
        11.15.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Verva Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Liver Diseases Therapeutics Drugs Industry Chain Analysis
    12.2 Liver Diseases Therapeutics Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Liver Diseases Therapeutics Drugs Production Mode & Process
    12.4 Liver Diseases Therapeutics Drugs Sales and Marketing
        12.4.1 Liver Diseases Therapeutics Drugs Sales Channels
        12.4.2 Liver Diseases Therapeutics Drugs Distributors
    12.5 Liver Diseases Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Liver Diseases Therapeutics Drugs Industry Trends
    13.2 Liver Diseases Therapeutics Drugs Market Drivers
    13.3 Liver Diseases Therapeutics Drugs Market Challenges
    13.4 Liver Diseases Therapeutics Drugs Market Restraints
14 Key Findings in The Global Liver Diseases Therapeutics Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral Liver Diseases Therapeutics Drugs
    Table 3. Major Manufacturers of Injection Liver Diseases Therapeutics Drugs
    Table 4. Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Liver Diseases Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Liver Diseases Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 7. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Liver Diseases Therapeutics Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 9. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Liver Diseases Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Liver Diseases Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Liver Diseases Therapeutics Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 15. Global Liver Diseases Therapeutics Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Liver Diseases Therapeutics Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 19. Global Liver Diseases Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Liver Diseases Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Therapeutics Drugs as of 2021)
    Table 21. Liver Diseases Therapeutics Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Liver Diseases Therapeutics Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Liver Diseases Therapeutics Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 26. Global Liver Diseases Therapeutics Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 27. Global Liver Diseases Therapeutics Drugs Sales Share by Type (2017-2022)
    Table 28. Global Liver Diseases Therapeutics Drugs Sales Share by Type (2023-2028)
    Table 29. Global Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Liver Diseases Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Liver Diseases Therapeutics Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Liver Diseases Therapeutics Drugs Revenue Share by Type (2023-2028)
    Table 33. Liver Diseases Therapeutics Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 34. Global Liver Diseases Therapeutics Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 35. Global Liver Diseases Therapeutics Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 36. Global Liver Diseases Therapeutics Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 37. Global Liver Diseases Therapeutics Drugs Sales Share by Application (2017-2022)
    Table 38. Global Liver Diseases Therapeutics Drugs Sales Share by Application (2023-2028)
    Table 39. Global Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Liver Diseases Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Liver Diseases Therapeutics Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Liver Diseases Therapeutics Drugs Revenue Share by Application (2023-2028)
    Table 43. Liver Diseases Therapeutics Drugs Price by Application (2017-2022) & (USD/Pcs)
    Table 44. Global Liver Diseases Therapeutics Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 45. North America Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 46. North America Liver Diseases Therapeutics Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 47. North America Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Liver Diseases Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Liver Diseases Therapeutics Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 50. North America Liver Diseases Therapeutics Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 51. North America Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Liver Diseases Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 54. North America Liver Diseases Therapeutics Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 55. North America Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Liver Diseases Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 58. Europe Liver Diseases Therapeutics Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 59. Europe Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Liver Diseases Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Liver Diseases Therapeutics Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 62. Europe Liver Diseases Therapeutics Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 63. Europe Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Liver Diseases Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 66. Europe Liver Diseases Therapeutics Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 67. Europe Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Liver Diseases Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 70. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 71. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 74. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 75. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 78. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 79. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 82. Latin America Liver Diseases Therapeutics Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 83. Latin America Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Liver Diseases Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Liver Diseases Therapeutics Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 86. Latin America Liver Diseases Therapeutics Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 87. Latin America Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Liver Diseases Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 90. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 91. Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 94. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 95. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 98. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 99. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 102. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 103. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. F. Hoffmann-La Roche Corporation Information
    Table 106. F. Hoffmann-La Roche Description and Major Businesses
    Table 107. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 108. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. F. Hoffmann-La Roche Recent Developments
    Table 110. Gilead Sciences Corporation Information
    Table 111. Gilead Sciences Description and Major Businesses
    Table 112. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 113. Gilead Sciences Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Gilead Sciences Recent Developments
    Table 115. GlaxoSmithKline Corporation Information
    Table 116. GlaxoSmithKline Description and Major Businesses
    Table 117. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 118. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. GlaxoSmithKline Recent Developments
    Table 120. Johnson & Johnson Corporation Information
    Table 121. Johnson & Johnson Description and Major Businesses
    Table 122. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 123. Johnson & Johnson Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Johnson & Johnson Recent Developments
    Table 125. Merck Corporation Information
    Table 126. Merck Description and Major Businesses
    Table 127. Merck Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 128. Merck Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Merck Recent Developments
    Table 130. Achillion Pharmaceuticals Corporation Information
    Table 131. Achillion Pharmaceuticals Description and Major Businesses
    Table 132. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 133. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Achillion Pharmaceuticals Recent Developments
    Table 135. AbbVie Corporation Information
    Table 136. AbbVie Description and Major Businesses
    Table 137. AbbVie Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 138. AbbVie Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. AbbVie Recent Developments
    Table 140. Angion Biomedica Corporation Information
    Table 141. Angion Biomedica Description and Major Businesses
    Table 142. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 143. Angion Biomedica Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Angion Biomedica Recent Developments
    Table 145. Bayer Corporation Information
    Table 146. Bayer Description and Major Businesses
    Table 147. Bayer Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 148. Bayer Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Bayer Recent Developments
    Table 150. LG Life Sciences Corporation Information
    Table 151. LG Life Sciences Description and Major Businesses
    Table 152. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 153. LG Life Sciences Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. LG Life Sciences Recent Developments
    Table 155. Phenex Pharmaceuticals Corporation Information
    Table 156. Phenex Pharmaceuticals Description and Major Businesses
    Table 157. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 158. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Phenex Pharmaceuticals Recent Developments
    Table 160. ProMetic Life Sciences Corporation Information
    Table 161. ProMetic Life Sciences Description and Major Businesses
    Table 162. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 163. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. ProMetic Life Sciences Recent Developments
    Table 165. Raptor Pharmaceuticals Corporation Information
    Table 166. Raptor Pharmaceuticals Description and Major Businesses
    Table 167. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 168. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Raptor Pharmaceuticals Recent Developments
    Table 170. Shenzhen Kangtai Biological Products Corporation Information
    Table 171. Shenzhen Kangtai Biological Products Description and Major Businesses
    Table 172. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 173. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Shenzhen Kangtai Biological Products Recent Developments
    Table 175. Verva Pharmaceuticals Corporation Information
    Table 176. Verva Pharmaceuticals Description and Major Businesses
    Table 177. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 178. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Verva Pharmaceuticals Recent Developments
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Liver Diseases Therapeutics Drugs Distributors List
    Table 183. Liver Diseases Therapeutics Drugs Customers List
    Table 184. Liver Diseases Therapeutics Drugs Market Trends
    Table 185. Liver Diseases Therapeutics Drugs Market Drivers
    Table 186. Liver Diseases Therapeutics Drugs Market Challenges
    Table 187. Liver Diseases Therapeutics Drugs Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Liver Diseases Therapeutics Drugs Product Picture
    Figure 3. Global Liver Diseases Therapeutics Drugs Market Share by Type in 2021 & 2028
    Figure 3. Oral Liver Diseases Therapeutics Drugs Product Picture
    Figure 4. Injection Liver Diseases Therapeutics Drugs Product Picture
    Figure 5. Global Liver Diseases Therapeutics Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Other
    Figure 9. Liver Diseases Therapeutics Drugs Report Years Considered
    Figure 10. Global Liver Diseases Therapeutics Drugs Sales 2017-2028 (K Pcs)
    Figure 11. Global Liver Diseases Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Liver Diseases Therapeutics Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Liver Diseases Therapeutics Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 17. North America Liver Diseases Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Liver Diseases Therapeutics Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 19. Europe Liver Diseases Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Liver Diseases Therapeutics Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 21. Asia-Pacific Liver Diseases Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Liver Diseases Therapeutics Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Latin America Liver Diseases Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Liver Diseases Therapeutics Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Middle East & Africa Liver Diseases Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Liver Diseases Therapeutics Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Liver Diseases Therapeutics Drugs in the World: Market Share by Liver Diseases Therapeutics Drugs Revenue in 2021
    Figure 28. Global Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Liver Diseases Therapeutics Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Liver Diseases Therapeutics Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Liver Diseases Therapeutics Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Liver Diseases Therapeutics Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Liver Diseases Therapeutics Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Liver Diseases Therapeutics Drugs Sales Share by Country (2017-2028)
    Figure 72. Latin America Liver Diseases Therapeutics Drugs Revenue Share by Country (2017-2028)
    Figure 73. Mexico Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Share by Country (2017-2028)
    Figure 82. Turkey Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Liver Diseases Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. Liver Diseases Therapeutics Drugs Value Chain
    Figure 86. Liver Diseases Therapeutics Drugs Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed